טוען...

TRAIL in cancer therapy: present and future challenges

Since its identification in 1995, TRAIL (TNF-Related Apoptosis Inducing Ligand) has sparked growing interest in oncology due to its reported ability to selectively trigger cancer cell death. Contrary to other members of the TNF superfamily, TRAIL administration in vivo is harmless. The relative abse...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Mérino, Delphine, Lalaoui, Najoua, Morizot, Alexandre, Solary, Eric, Micheau, Olivier
פורמט: Artigo
שפה:Inglês
יצא לאור: Informa Healthcare 2007
נושאים:
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC2976473/
https://ncbi.nlm.nih.gov/pubmed/17907960
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1517/14728222.11.10.1299
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!